Home › Companies › DECIPHERA PHARMACEUTICALS INC. › 2023-2024
At DECIPHERA PHARMACEUTICALS INC.'s shareholder meeting held June 12, 2024, in the 2023-2024 proxy season, 50 asset managers reported how they voted in their SEC Form N-PX filings, covering 184 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding, advisory basis, the compensation of our named executive officers… — the reporting funds and managers cast 99.8% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings. Page generated November 8, 2026.
No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from DECIPHERA PHARMACEUTICALS INC. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore DECIPHERA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
Each item below shows how the 50 asset managers that disclosed a DECIPHERA PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DECIPHERA PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
5% of fund votes cast · no official result
The 14 asset managers below reported 45,363 for, 864,699 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 0 | 0 | 0 | 434,143 | Withhold |
| Principal | 0 | 0 | 0 | 285,783 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 104,476 | Withhold |
| John Hancock | 0 | 0 | 0 | 20,365 | Withhold |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 17,063 | Withhold |
| Managed Portfolio Series | 7,514 | 0 | 0 | 0 | For |
| Allianz | 0 | 0 | 0 | 2,869 | Withhold |
| Pacer Funds Trust | 949 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 145 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Northern Lights Fund Trust IV | 0 | 0 | 0 | 0 | -- |
4% of fund votes cast · no official result
The 14 asset managers below reported 37,704 for, 872,358 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 0 | 0 | 0 | 434,143 | Withhold |
| Principal | 0 | 0 | 0 | 285,783 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 104,476 | Withhold |
| John Hancock | 0 | 0 | 0 | 20,365 | Withhold |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 17,063 | Withhold |
| Managed Portfolio Series | 0 | 0 | 0 | 7,514 | Withhold |
| Allianz | 0 | 0 | 0 | 2,869 | Withhold |
| Pacer Funds Trust | 949 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 145 | Withhold |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Northern Lights Fund Trust IV | 0 | 0 | 0 | 0 | -- |
7% of fund votes cast · no official result
The 14 asset managers below reported 65,583 for, 844,479 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 0 | 0 | 0 | 434,143 | Withhold |
| Principal | 0 | 0 | 0 | 285,783 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 104,476 | Withhold |
| John Hancock | 20,365 | 0 | 0 | 0 | For |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 17,063 | Withhold |
| Managed Portfolio Series | 7,514 | 0 | 0 | 0 | For |
| Allianz | 0 | 0 | 0 | 2,869 | Withhold |
| Pacer Funds Trust | 949 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 145 | Withhold |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Northern Lights Fund Trust IV | 0 | 0 | 0 | 0 | -- |
99.0% of fund votes cast · no official result
Description as filed by funds: TO APPROVE AN AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO PERMIT LIMITATION OF LIABILITY OF CERTAIN DECIPHERA PHARMACEUTICALS, INC. OFFICERS AS AND TO THE EXTENT PROVIDED AND PERMITTED BY SECTION 102(B)(7) OF THE GENERAL CORPORATION LAW OF DELAWARE.
The 14 asset managers below reported 901,599 for, 8,463 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 434,143 | 0 | 0 | 0 | For |
| Principal | 285,783 | 0 | 0 | 0 | For |
| Prudential/PGIM | 104,476 | 0 | 0 | 0 | For |
| John Hancock | 20,365 | 0 | 0 | 0 | For |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 17,063 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 0 | 7,514 | 0 | 0 | Against |
| Allianz | 2,869 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 0 | 949 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 145 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Northern Lights Fund Trust IV | 0 | 0 | 0 | 0 | -- |
100% of fund votes cast · no official result
Description as filed by funds: To approve an amendment to the Amended and Restated Certificate of Incorporation of Deciphera Pharmaceuticals, Inc. ("Certificate of Incorporation") to increase the number of authorized shares of our common stock, $0.01 par value per share, from 125,000,000 to 250,000,000.
The 13 asset managers below reported 909,917 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 434,143 | 0 | 0 | 0 | For |
| Principal | 285,783 | 0 | 0 | 0 | For |
| Prudential/PGIM | 104,476 | 0 | 0 | 0 | For |
| John Hancock | 20,365 | 0 | 0 | 0 | For |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 17,063 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 7,514 | 0 | 0 | 0 | For |
| Allianz | 2,869 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 949 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Northern Lights Fund Trust IV | 0 | 0 | 0 | 0 | -- |
99.0% of fund votes cast · no official result
Description as filed by funds: TO APPROVE THE ADJOURNMENT OF THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO THE EXTENT THERE ARE INSUFFICIENT VOTES AT THE ANNUAL MEETING TO APPROVE THE PROPOSALS MENTIONED IN ITEMS 4 AND 5 ABOVE.
The 14 asset managers below reported 901,599 for, 8,463 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 434,143 | 0 | 0 | 0 | For |
| Principal | 285,783 | 0 | 0 | 0 | For |
| Prudential/PGIM | 104,476 | 0 | 0 | 0 | For |
| John Hancock | 20,365 | 0 | 0 | 0 | For |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 17,063 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 0 | 7,514 | 0 | 0 | Against |
| Allianz | 2,869 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 0 | 949 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 145 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Northern Lights Fund Trust IV | 0 | 0 | 0 | 0 | -- |
Combines 3 wordings of this item as funds reported it.
99.8% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this notice.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 434,143 | 0 | 0 | 0 | For |
| Principal | 285,783 | 0 | 0 | 0 | For |
| Prudential/PGIM | 104,476 | 0 | 0 | 0 | For |
| John Hancock | 20,365 | 0 | 0 | 0 | For |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 17,063 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 7,514 | 0 | 0 | 0 | For |
| Allianz | 2,869 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 949 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 145 | 0 | 0 | 0 | For |
Fund voting reports, all 11 managers: 910,062 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EMERALD MUTUAL FUND ADVISERS TRUST | 824,402 | 0 | 0 | 0 | For |
| EMERALD ADVISERS, LLC | 578,946 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 23,111 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 22,731 | 0 | 0 | 0 | For |
| INTRUST BANK NA | 13,805 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 12,128 | 0 | 0 | 0 | For |
| STONERIDGE INVESTMENT PARTNERS LLC | 6,762 | 0 | 0 | 0 | For |
| Edmonds Duncan Registered Investment Advisors, LLC | 4,795 | 0 | 0 | 0 | For |
| CORNERCAP INVESTMENT COUNSEL INC | 3,835 | 0 | 0 | 0 | For |
| Northern Trust | 3,218 | 35 | 0 | 0 | For |
| Empirical Asset Management, LLC | 0 | 3,000 | 0 | 0 | Against |
| XPONANCE, INC. | 2,764 | 0 | 0 | 0 | For |
| Pitcairn Trust Co LLC | 1,930 | 0 | 0 | 0 | For |
| ATWOOD & PALMER INC | 1,811 | 0 | 0 | 0 | For |
| COMMERCE BANK | 1,500 | 0 | 0 | 0 | For |
| Bleakley Financial Group, LLC | 1,160 | 0 | 0 | 0 | For |
| Capital Group | 912 | 0 | 0 | 0 | For |
| Natixis | 566 | 0 | 0 | 0 | For |
| CHOREO, LLC | 425 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 424 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 302 | 0 | 0 | 0 | For |
| First Trust | 286 | 0 | 0 | 0 | For |
| COLDSTREAM CAPITAL MANAGEMENT INC | 156 | 0 | 0 | 0 | For |
| L2 Asset Management, LLC | 145 | 0 | 0 | 0 | For |
| Savant Capital, LLC | 127 | 0 | 0 | 0 | For |
Institutional-manager reports, all 34 managers: 1,506,655 for, 3,035 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as Deciphera Pharmaceuticals, Inc.'s independent registered public accounting firm for the year ending December 31, 2024.
The 14 asset managers below reported 909,917 for, 145 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FINANCIAL INVESTORS TRUST | 434,143 | 0 | 0 | 0 | For |
| Principal | 285,783 | 0 | 0 | 0 | For |
| Prudential/PGIM | 104,476 | 0 | 0 | 0 | For |
| John Hancock | 20,365 | 0 | 0 | 0 | For |
| Tema ETF Trust | 18,633 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,122 | 0 | 0 | 0 | For |
| Jackson National | 17,063 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 7,514 | 0 | 0 | 0 | For |
| Allianz | 2,869 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 949 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 145 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Northern Lights Fund Trust IV | 0 | 0 | 0 | 0 | -- |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | FINANCIAL INVESTORS TRUST | 434,143 |
| 2 | Principal | 285,783 |
| 3 | Prudential/PGIM | 104,476 |
| 4 | John Hancock | 20,365 |
| 5 | Tema ETF Trust | 18,633 |
| 6 | Bridge Builder Trust | 18,122 |
| 7 | Jackson National | 17,063 |
| 8 | Managed Portfolio Series | 7,514 |
| 9 | Allianz | 2,869 |
| 10 | Pacer Funds Trust | 949 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | EMERALD MUTUAL FUND ADVISERS TRUST | 824,402 |
| 2 | EMERALD ADVISERS, LLC | 578,946 |
| 3 | GREAT POINT PARTNERS LLC | 23,111 |
| 4 | ENVESTNET ASSET MANAGEMENT INC | 22,731 |
| 5 | INTRUST BANK NA | 13,805 |
| 6 | ROCKEFELLER FINANCIAL LLC | 12,128 |
| 7 | STONERIDGE INVESTMENT PARTNERS LLC | 6,762 |
| 8 | Edmonds Duncan Registered Investment Advisors, LLC | 4,795 |
| 9 | CORNERCAP INVESTMENT COUNSEL INC | 3,835 |
| 10 | Northern Trust | 3,253 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to DECIPHERA PHARMACEUTICALS INC. for the 2023-2024 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
DECIPHERA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page).
proxyvotesnow.com, “DECIPHERA PHARMACEUTICALS INC. 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/deciphera-pharmaceuticals-inc/2024 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.